Long term conditions

NHS England strikes deal to make innovative Multiple Sclerosis drug available, paving the way for NICE recommendation

Patients with Multiple Sclerosis (MS) will have routine access to a drug that can slow disability under a deal struck between NHS England and the manufacturer Roche, paving the way for its approval by NICE. Ocrelizumab (also known as Ocrevus) is the first treatment that can modify or change the course of the disease to […]

Read more

NHS England and UK Space Agency launch multi-million pound drive to improve patient care

The UK Space Agency has today announced that it is allocating up to £4 million to find hi-tech solutions to the major health and care challenges facing the NHS in its 70th anniversary year in a joint initiative with NHS England. These challenges, outlined by NHS England’s chief executive Simon Stevens in his speech to […]

Read more

NHS England strikes new deals to make two new innovative treatments available routinely on the NHS

NHS chief Simon Stevens will today announce that NHS England has struck deals to make innovative treatments for Multiple Sclerosis and breast cancer routinely available on the NHS. From tomorrow (10 November) hundreds of patients with Multiple Sclerosis are set to benefit from a new treatment option, Mavenclad, following a deal with drug company Merck. […]

Read more

Health service embracing innovation as NHS England announces major trials to improve patient care

Older patients and people with long term conditions and mental health problems will be among the first to benefit from a major new drive to modernise how the NHS delivers care. Speaking at the World Economic Forum in Davos today (Friday 22), NHS England Chief Executive Simon Stevens will launch the first wave of NHS […]

Read more